http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107144648-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
filingDate 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107144648-B
titleOfInvention Detect the liquid chromatography-tandem mass spectrometry method of Pitavastatin in human plasma
abstract The present invention relates to the liquid chromatography-tandem mass spectrometry methods of Pitavastatin in detection human plasma.The present invention provides the methods of Pitavastatin concentration in detection blood plasma, are analyzed by LC-MS/MS Pitavastatin concentration in blood plasma.The method of the present invention preferably uses albumen precipitation preprocess method, using deuterated Pitavastatin as internal standard, using Eclipse Plus Phenyl-Hexyl column isocratic elution, the detection of electrospray ionisation source (ESI) tandem mass spectrum.The plasma sample extraction recovery of the method for the present invention is set to be greater than 93%, it is not influenced by matrix effect, Pitavastatin stability is investigated using statistics Pitavastatin concentration RSD% before pretreatment, guarantee the accuracy of determination data, its specificity selectivity is strong, high sensitivity, detection is quick, dosage is small, meets simple, reliable, the clinical batch samples of high-throughput, condition controllably and analyzes demand.Specificity, stability of the method for the present invention etc. are verified, and the bioequivalence of evaluation each dosage form of Pitavastatin is successfully used for.
priorityDate 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451679761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452349496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18373917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424642966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448540569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9801294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350

Total number of triples: 44.